Published Date: 02 Mar 2023
When adults with cancer take many medications, including blood pressure medications, supplements, or over-the-counter medications such as immunosuppressants, more toxic antibiotics may occur and may lead to the need to avoid the cancer.
Read Full NewsA leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
(Refiles to remove extraneous word years from first paragraph)
The Moderna vaccine will likely be available in Europe long before the US.
Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.
Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.
In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.
Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.
1.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
2.
Do I qualify for a cancer clinical trial?
3.
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma
4.
Novel biomarker has potential for predicting and treating skin cancer metastasis
5.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
1.
New Research on Craniopharyngioma
2.
Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges
3.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
4.
Uncovering the Mysteries of the RDW Blood Test
5.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation